This post was originally published on News-medical.net
You will shortly be re-directed to the publisher's website
A new clinical trial, sponsored by UCL and UCLH, aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile of their tumor.